Entresto(LCZ696)是一种*新药,用于治疗NYHA Ⅱ—Ⅳ级心衰患者,以多种方式作用于心脏的神经内分泌系统,该药是过去25年内心衰治疗领域的一个伟大突破,有望成功动摇过去10年未被修改的心衰治疗整体框架。entresto是结合sacubitril,一脑啡肽酶抑制剂,和缬沙坦,血管紧张素Ⅱ受体阻断剂,以减少风险心力衰竭患者的心血管死亡及住院治疗慢性心力衰竭(NYHAII-IV级)和射血分数降低。
深圳远扬化学可提供LCZ696申报所用全套杂质, 随货附CoA证书,HNMR,MS,HPLC图谱,纯度符合申报要求,欢迎我司(何,,phastandards, )。请点击本页标题下方“进入该公司展台” 查看我司信息。
部分杂质现货,欢迎详询
LCZ696 Impurity 1 | (2R,4R)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | C23H29NO4 | 383.48 |
LCZ696 Impurity 2 | (2S,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | C23H29NO4 | 383.48 |
LCZ696 Impurity 3 | (2S,4R)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid | C23H29NO4 | 383.48 |
LCZ696 Impurity 4 | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoic acid | C18H21NO2 | 283.36 |
LCZ696 Impurity 5 | (3R,5S)-5-([1,1'-biphenyl]-4-ylmethyl)-3- | C18H19NO | 265.35 |
LCZ696 Impurity 6 | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid | C22H25NO5 | 383.44 |
LCZ696 Impurity 7 | (2R,4R)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate | C20H25NO2 | 311.42 |
LCZ696 Impurity 8 | (2S,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate | C20H25NO2 | 311.42 |
LCZ696 Impurity 9 | (2S,4R)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate | C20H25NO2 | 311.42 |
LCZ696 Impurity 10 | 4-(((2R,4S)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid | C24H29NO5 | 411.49 |
LCZ696 Impurity 11 | 4-(((2S,4S)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid | C24H29NO5 | 411.49 |
LCZ696 Impurity 12 | 4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid | C24H29NO5 | 411.49 |
LCZ696 Impurity 13 | (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(2,5-dioxopyrrolidin-1-yl)-2-methylpentanoic acid | C22H23NO4 | 365.42 |
LCZ696 Impurity 14 | 4-((3R,5S)-5-([1,1'-biphenyl]-4-ylmethyl)-3-methyl-2-oxopyrrolidin-1-yl)-4-oxobutanoic acid | C22H23NO4 | 365.42 |